BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 20696768)

  • 1. Rod/Zw10 complex is required for PIASy-dependent centromeric SUMOylation.
    Ryu H; Azuma Y
    J Biol Chem; 2010 Oct; 285(42):32576-85. PubMed ID: 20696768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a new small ubiquitin-like modifier (SUMO)-interacting motif in the E3 ligase PIASy.
    Kaur K; Park H; Pandey N; Azuma Y; De Guzman RN
    J Biol Chem; 2017 Jun; 292(24):10230-10238. PubMed ID: 28455449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PIASy mediates SUMO-2/3 conjugation of poly(ADP-ribose) polymerase 1 (PARP1) on mitotic chromosomes.
    Ryu H; Al-Ani G; Deckert K; Kirkpatrick D; Gygi SP; Dasso M; Azuma Y
    J Biol Chem; 2010 May; 285(19):14415-23. PubMed ID: 20228053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SUMOylation regulates polo-like kinase 1-interacting checkpoint helicase (PICH) during mitosis.
    Sridharan V; Park H; Ryu H; Azuma Y
    J Biol Chem; 2015 Feb; 290(6):3269-76. PubMed ID: 25564610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PIASy-dependent SUMOylation regulates DNA topoisomerase IIalpha activity.
    Ryu H; Furuta M; Kirkpatrick D; Gygi SP; Azuma Y
    J Cell Biol; 2010 Nov; 191(4):783-94. PubMed ID: 21079245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PIASy mediates SUMO-2 conjugation of Topoisomerase-II on mitotic chromosomes.
    Azuma Y; Arnaoutov A; Anan T; Dasso M
    EMBO J; 2005 Jun; 24(12):2172-82. PubMed ID: 15933717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human Zwint-1 specifies localization of Zeste White 10 to kinetochores and is essential for mitotic checkpoint signaling.
    Wang H; Hu X; Ding X; Dou Z; Yang Z; Shaw AW; Teng M; Cleveland DW; Goldberg ML; Niu L; Yao X
    J Biol Chem; 2004 Dec; 279(52):54590-8. PubMed ID: 15485811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PIASy-mediated sumoylation of Yin Yang 1 depends on their interaction but not the RING finger.
    Deng Z; Wan M; Sui G
    Mol Cell Biol; 2007 May; 27(10):3780-92. PubMed ID: 17353273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SUMO-2/3 modification and binding regulate the association of CENP-E with kinetochores and progression through mitosis.
    Zhang XD; Goeres J; Zhang H; Yen TJ; Porter AC; Matunis MJ
    Mol Cell; 2008 Mar; 29(6):729-41. PubMed ID: 18374647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poly-SUMO-2/3 chain modification of Nuf2 facilitates CENP-E kinetochore localization and chromosome congression during mitosis.
    Subramonian D; Chen TA; Paolini N; Zhang XD
    Cell Cycle; 2021 May; 20(9):855-873. PubMed ID: 33910471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PIASy mediates NEMO sumoylation and NF-kappaB activation in response to genotoxic stress.
    Mabb AM; Wuerzberger-Davis SM; Miyamoto S
    Nat Cell Biol; 2006 Sep; 8(9):986-93. PubMed ID: 16906147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RanBP2 and SENP3 function in a mitotic SUMO2/3 conjugation-deconjugation cycle on Borealin.
    Klein UR; Haindl M; Nigg EA; Muller S
    Mol Biol Cell; 2009 Jan; 20(1):410-8. PubMed ID: 18946085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spatial interplay between PIASy and FIP200 in the regulation of signal transduction and transcriptional activity.
    Martin N; Schwamborn K; Urlaub H; Gan B; Guan JL; Dejean A
    Mol Cell Biol; 2008 Apr; 28(8):2771-81. PubMed ID: 18285457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ZW10 links mitotic checkpoint signaling to the structural kinetochore.
    Kops GJ; Kim Y; Weaver BA; Mao Y; McLeod I; Yates JR; Tagaya M; Cleveland DW
    J Cell Biol; 2005 Apr; 169(1):49-60. PubMed ID: 15824131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SUMO-1 modification of PIASy, an E3 ligase, is necessary for PIASy-dependent activation of Tcf-4.
    Ihara M; Yamamoto H; Kikuchi A
    Mol Cell Biol; 2005 May; 25(9):3506-18. PubMed ID: 15831457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein inhibitor of activated STAT Y (PIASy) and a splice variant lacking exon 6 enhance sumoylation but are not essential for embryogenesis and adult life.
    Wong KA; Kim R; Christofk H; Gao J; Lawson G; Wu H
    Mol Cell Biol; 2004 Jun; 24(12):5577-86. PubMed ID: 15169916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PIASy is a SUMOylation-independent negative regulator of the insulin transactivator MafA.
    Onishi S; Kataoka K
    J Mol Endocrinol; 2019 Nov; 63(4):297-308. PubMed ID: 31614335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PIASy-mediated repression of the androgen receptor is independent of sumoylation.
    Gross M; Yang R; Top I; Gasper C; Shuai K
    Oncogene; 2004 Apr; 23(17):3059-66. PubMed ID: 14981544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SUMOylation of the C-terminal domain of DNA topoisomerase IIα regulates the centromeric localization of Claspin.
    Ryu H; Yoshida MM; Sridharan V; Kumagai A; Dunphy WG; Dasso M; Azuma Y
    Cell Cycle; 2015; 14(17):2777-84. PubMed ID: 26131587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conjugation of human topoisomerase 2 alpha with small ubiquitin-like modifiers 2/3 in response to topoisomerase inhibitors: cell cycle stage and chromosome domain specificity.
    Agostinho M; Santos V; Ferreira F; Costa R; Cardoso J; Pinheiro I; Rino J; Jaffray E; Hay RT; Ferreira J
    Cancer Res; 2008 Apr; 68(7):2409-18. PubMed ID: 18381449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.